The company's early cancer detection test utilizes a ctDNA mutationcentered analytical approach that is combined with advanced machine learning and artificial intelligence. SeekInCare is their test for early detection of pancreatic cancer. OncoSeek, their multi-cancer early detection test which includes both pancreatic and liver cancer received European CE mark approval in September 2022. 208 Tzar Labs, Singapore Developer of a non-invasive hepatocellular carcinoma detection test. The company's technology helps in the detection of tumors by using embryoniclike stem cells and cancer stem cells for diagnostics, therefore helping to detect cancer including pancreatic and liver, even years before the symptoms occur.